» Articles » PMID: 9931295

Tyrosine Phosphatase SHP-2 Dephosphorylates the Platelet-derived Growth Factor Receptor but Enhances Its Downstream Signalling

Overview
Journal Biochem J
Specialty Biochemistry
Date 1999 Feb 5
PMID 9931295
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

SHP-2 is a widely distributed Src homology 2 (SH2) domain-containing tyrosine phosphatase that is recruited to growth factor receptors on stimulation. We have transiently co-expressed several catalytically active and inactive forms of the enzyme with the platelet-derived growth factor (PDGF) receptor in human embryonic kidney 293 cells. The catalytically active forms of SHP-2 decreased the tyrosine phosphorylation of the receptor, whereas the catalytically inactive forms increased the phosphorylation. However, PDGF-induced activation of the mitogen-activated protein (MAP) kinase pathway was enhanced by the active forms of SHP-2 but decreased by the inactive forms. The results suggest that the PDGF receptor is a physiological substrate of SHP-2 and that SHP-2 has a positive role in the PDGF-stimulated activation of MAP kinase. The dissociation of the receptor phosphorylation from the activation of MAP kinase suggests that signalling through growth factor receptors does not depend merely on their tyrosine phosphorylation.

Citing Articles

PI3K inhibition circumvents resistance to SHP2 blockade in metastatic triple-negative breast cancer.

Amante R, Jehanno C, De Silva D, Coissieux M, Ackerknecht M, Romanet V J Mammary Gland Biol Neoplasia. 2023; 28(1):13.

PMID: 37294349 PMC: 10256672. DOI: 10.1007/s10911-023-09539-9.


Off-target inhibition by active site-targeting SHP2 inhibitors.

Tsutsumi R, Ran H, Neel B FEBS Open Bio. 2018; 8(9):1405-1411.

PMID: 30186742 PMC: 6120237. DOI: 10.1002/2211-5463.12493.


Antagonism or synergism. Role of tyrosine phosphatases SHP-1 and SHP-2 in growth factor signaling.

Wang N, Li Z, Ding R, Frank G, Senbonmatsu T, Landon E J Biol Chem. 2006; 281(31):21878-21883.

PMID: 16762922 PMC: 2377019. DOI: 10.1074/jbc.M605018200.


Divergent roles of c-Src in controlling platelet-derived growth factor-dependent signaling in fibroblasts.

Shah K, Vincent F Mol Biol Cell. 2005; 16(11):5418-32.

PMID: 16135530 PMC: 1266437. DOI: 10.1091/mbc.e05-03-0263.


Interferon-gamma-dependent tyrosine phosphorylation of MEKK4 via Pyk2 is regulated by annexin II and SHP2 in keratinocytes.

Halfter U, Derbyshire Z, Vaillancourt R Biochem J. 2004; 388(Pt 1):17-28.

PMID: 15601262 PMC: 1186689. DOI: 10.1042/BJ20041236.


References
1.
Seger R, Ahn N, Posada J, Munar E, Jensen A, Cooper J . Purification and characterization of mitogen-activated protein kinase activator(s) from epidermal growth factor-stimulated A431 cells. J Biol Chem. 1992; 267(20):14373-81. View

2.
Perkins L, Larsen I, Perrimon N . corkscrew encodes a putative protein tyrosine phosphatase that functions to transduce the terminal signal from the receptor tyrosine kinase torso. Cell. 1992; 70(2):225-36. DOI: 10.1016/0092-8674(92)90098-w. View

3.
Tanaka A, Gibbs C, Arthur R, Anderson S, Kung H, Fujita D . DNA sequence encoding the amino-terminal region of the human c-src protein: implications of sequence divergence among src-type kinase oncogenes. Mol Cell Biol. 1987; 7(5):1978-83. PMC: 365305. DOI: 10.1128/mcb.7.5.1978-1983.1987. View

4.
Chen C, Okayama H . High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol. 1987; 7(8):2745-52. PMC: 367891. DOI: 10.1128/mcb.7.8.2745-2752.1987. View

5.
Bouchard P, Zhao Z, Banville D, Dumas F, FISCHER E, Shen S . Phosphorylation and identification of a major tyrosine phosphorylation site in protein tyrosine phosphatase 1C. J Biol Chem. 1994; 269(30):19585-9. View